Skip to main content
. 2009 Jun 30;3(2):108–115. doi: 10.5009/gnl.2009.3.2.108

Fig. 2.

Fig. 2

BMI, fasting plasma glucose, fasting serum insulin, and HOMA-IR before and after antiviral treatment in sustained responders (A, n=22) and nonresponders (B, n=6). Data were obtained before and at 6 months after the end of antiviral treatment. Bar and vertical line is mean and SD value, respectively.

*p<0.05, p<0.01.

BMI, body mass index; NS, not significant.